136 related articles for article (PubMed ID: 8769538)
1. A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD.
Teramoto S; Fukuchi Y; Ouchi Y
Chest; 1996 Jun; 109(6):1666-7. PubMed ID: 8769538
[No Abstract] [Full Text] [Related]
2. Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD?
Blosser SA; Maxwell SL; Reeves-Hoche MK; Localio AR; Zwillich CW
Chest; 1995 Sep; 108(3):730-5. PubMed ID: 7656624
[TBL] [Abstract][Full Text] [Related]
3. Apples and oranges : flaws and guffaws.
Petty TL
Chest; 1999 Oct; 116(4):1137-8. PubMed ID: 10531190
[No Abstract] [Full Text] [Related]
4. Efficacy of salmeterol xinafoate in the treatment of COPD.
Mahler DA; Donohue JF; Barbee RA; Goldman MD; Gross NJ; Wisniewski ME; Yancey SW; Zakes BA; Rickard KA; Anderson WH
Chest; 1999 Apr; 115(4):957-65. PubMed ID: 10208192
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic bronchodilators.
Witek TJ
Respir Care Clin N Am; 1999 Dec; 5(4):521-36. PubMed ID: 10565879
[TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of inhaled anticholinergic therapy.
Campbell SC
Respir Care; 2000 Jul; 45(7):864-7. PubMed ID: 10926384
[TBL] [Abstract][Full Text] [Related]
7. Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials.
Haney S; Hancox RJ
Respir Res; 2007 Mar; 8(1):19. PubMed ID: 17341317
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
Pillet O; Manier G; Castaing Y
Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
[TBL] [Abstract][Full Text] [Related]
9. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Ikeda A; Nishimura K; Izumi T
Chest; 1996 Jan; 109(1):294. PubMed ID: 8549208
[No Abstract] [Full Text] [Related]
10. [Clinical aspects of anticholinergic agents].
Friedman M
Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
[No Abstract] [Full Text] [Related]
11. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Ingram RH
Chest; 1996 Jan; 109(1):293. PubMed ID: 8549206
[No Abstract] [Full Text] [Related]
12. [Nebulization in worsening of chronic obstructive lung diseases: importance of anticholinergic agents. The Multicenter Group].
Cuvelier A; Muir JF
Ann Fr Anesth Reanim; 1998; 17 Suppl 2():48s-51s. PubMed ID: 9881209
[TBL] [Abstract][Full Text] [Related]
13. [Current strategy of bronchodilator therapy for chronic obstructive pulmonary disease (COPD)].
Teramoto S
Nihon Rinsho; 1999 Sep; 57(9):2051-5. PubMed ID: 10497405
[TBL] [Abstract][Full Text] [Related]
14. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328
[TBL] [Abstract][Full Text] [Related]
15. Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease.
Cook D; Guyatt G; Wong E; Goldstein R; Bedard M; Austin P; Ramsdale H; Jaeschke R; Sears M
Am J Respir Crit Care Med; 2001 Jan; 163(1):85-90. PubMed ID: 11208630
[TBL] [Abstract][Full Text] [Related]
16. A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD.
Karpel JP; Kotch A; Zinny M; Pesin J; Alleyne W
Chest; 1994 Apr; 105(4):1089-94. PubMed ID: 8162730
[TBL] [Abstract][Full Text] [Related]
17. Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease?
Hatipoğlu U; Laghi F; Tobin MJ
Am J Respir Crit Care Med; 1999 Dec; 160(6):1916-21. PubMed ID: 10588606
[TBL] [Abstract][Full Text] [Related]
18. [Beta2-agonists and anticholinergic agents].
Madsen FF
Ugeskr Laeger; 1997 Mar; 159(10):1470-1. PubMed ID: 9082639
[No Abstract] [Full Text] [Related]
19. [Treatment of COPD in primary care].
Golpe Gómez R; Mateos Colino A
Arch Bronconeumol; 2000 Mar; 36(3):167. PubMed ID: 10782272
[No Abstract] [Full Text] [Related]
20. Relative and additional bronchodilator response of salbutamol and ipratropium in smoker and nonsmoker asthmatics.
Ahmad Z; Singh SK
J Asthma; 2010 Apr; 47(3):340-3. PubMed ID: 20394521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
